[1]党樊聘,陈萌珂,张黎军,等.丹参多酚酸对急性大动脉粥样硬化型脑卒中的临床治疗效果[J].新乡医学院学报,2020,37(7):681-686.[doi:10.7683/xxyxyxb.2020.07.020]
　DANG Fanpin,CHEN Mengke,ZHANG Lijun,et al.Clinical effect of salvianolic acid on acute large artery atherosclerotic stroke[J].Journal of Xinxiang Medical University,2020,37(7):681-686.[doi:10.7683/xxyxyxb.2020.07.020]
点击复制

丹参多酚酸对急性大动脉粥样硬化型脑卒中的临床治疗效果
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
37
期数:
2020年7
页码:
681-686
栏目:
临床研究
出版日期:
2020-07-05

文章信息/Info

Title:
Clinical effect of salvianolic acid on acute large artery atherosclerotic stroke
作者:
党樊聘; 陈萌珂; 张黎军; 王园春; 袁　彬
（新乡医学院第一附属医院神经内科，河南　卫辉　453100）
Author(s):
DANG Fanpin; CHEN Mengke; ZHANG Lijun; WANG Yuanchun; YUAN Bin
(Department of Neurology，the First Affiliated Hospital of Xinxiang Medical University，Weihui 453100，Henan Province,China)
关键词:
急性大动脉粥样硬化型脑卒中; 丹参多酚酸; 美国国立卫生研究院卒中量表; 改良Barthel指数量表; 细胞间黏附分子-1
Keywords:
acute large artery atherosclerotic stroke; salvianolic acid; National Institutes of Health stroke scale; modified Barthel index; intercellular cell adhesion molecule-1
分类号:
R743.3
DOI:
10.7683/xxyxyxb.2020.07.020
文献标志码:
A
摘要:
目的　观察丹参多酚酸对急性大动脉粥样硬化（LAA）型脑卒中患者的临床治疗效果及其作用机制。方法　选择2018年11月至2019年11月新乡医学院第一附属医院收治的200例急性LAA型脑卒中患者为观察对象，使用随机数字表法将患者分为对照组和干预组，并根据入院时美国国立卫生研究院卒中量表（NIHSS）评分将各组患者分为轻、中、重度卒中组。所有患者给予常规治疗，干预组在常规治疗基础上给予注射用丹参多酚酸静脉滴注，连用14 d；对照组患者在常规治疗基础上给予等量生理盐水静脉滴注。分别于治疗前及治疗14 d后采用NIHSS、改良Barthel指数量表（MBI）评估患者的神经功能缺损和日常生活能力，并根据NIHSS评分变化程度比较对照组与干预组患者的治疗效果；采用酶联免疫吸附试验检测2组患者治疗前后血清细胞间黏附分子-1（ICAM-1）水平；观察2组患者不良事件发生情况。结果　干预组患者中途自动退出8例，对照组患者中途自动退出7例，干预组和对照组最终纳入患者分别为92例、93例。2组患者治疗前NIHSS、MBI评分比较差异无统计学意义（P>0.05）。治疗14 d后，2组患者的NIHSS评分与治疗前比较均显著降低（P<0.05），MBI评分与治疗前比较均显著增高（P<0.05）；治疗14 d后，干预组患者的NIHSS评分显著低于对照组（P<0.05），MBI评分显著高于对照组（P<0.05）。治疗后，干预组患者基本痊愈5例，显著进步44例，进步31例，无效10例，恶化2例，有效率为87.0%(80/92)；对照组患者基本痊愈2例，显著进步16例，进步36例，无效33例，恶化6例，有效率为58.1%（54/93）；干预组患者的有效率显著高于对照组（χ2=19.334，P<0.05）。2组轻度卒中患者的有效率比较差异无统计学意义（χ2=0.366，P>0.05），干预组中、重度卒中患者的有效率显著高于对照组（χ2=12.752、8.713，P<0.05）。治疗前2组患者血清ICAM-1水平比较差异无统计学意义（Z=-1.213，P>0.05）；治疗后2组患者血清ICAM-1水平与治疗前比较均显著降低（Z=-5.238、-7.969，P<0.05），且干预组患者血清ICAM-1水平显著低于对照组（Z=-6.644，P<0.05）。治疗期间，干预组2例（2.2%）患者出现头晕、血压下降，对照组患者未发生类似不良反应；2组患者均未发生过敏反应。结论　丹参多酚酸可有效改善急性LAA型脑卒中患者的神经功能，提高日常生活能力，其机制可能是通过降低血清中ICAM-1水平、阻断缺血脑组织炎症级联反应而发挥治疗作用。
Abstract:
Objective　To observe the clinical effect of salvianolic acid on acute large artery atherosclerosis (LAA) stroke and explore its mechanism.Methods　Two hundred patients with acute LAA stroke admitted to the First Affiliated Hospital of Xinxiang Medical University from November 2018 to November 2019 were selected as observation subjects,and they were randomly divided into control group and intervention group according to the random number table.According to the score of National Institutes of Health stroke scale (NIHSS) at admission,the patients in each group were divided into mild,moderate and severe stroke groups.All patients were given routine treatment,while the patients in the intervention group was given salvianolic acid for injection by intravenous drip for 14 days,the patients in the control group was given same amount of normal saline by intravenous drip.The NIHSS and Modified Barthel Index scale (MBI) were used to evaluate the neurological deficit and activities of daily living before and at 14 days after treatment,and the efficacy of the two groups were compared according to the changes of NIHSS score.The serum intercellular adhesion molecule-1 (ICAM-1) level was detected by enzyme-linked immunosorbent assay.The adverse events of the patients in the two groups were observed.Results　Eight patients in the intervention group and seven patients in the control group were automatically dropped out.Ninety-two cases and Ninety-three cases were included in the intervention group and the control group,respectively.There was no significant difference in the NIHSS and MBI scores between the two groups before treatment (P<0.05).After 14 days of treatment,the NIHSS score of patients in the the two groups was significantly lower than that before treatment (P<0.05),and the MBI score of patients in the two groups was significantly higher than that before treatment (P<0.05).After 14 days of treatment,the NIHSS score in the intervention group was significantly lower than that in the control group,and the MBI score in the intervention group was significantly higher than that in the control group (P<0.05).After treatment,5 cases in the intervention group were basically cured,44 cases were significantly improved,31 cases improved,10 cases were ineffective,2 cases were deteriorated,and the effective rate was 87.0% (80/92).In the control group,2 case were basically cured,16 cases were significantly improved,36 cases were improved,33 cases were ineffective,6 cases were deteriorated,and the effective rate was 58.1% (54/93).The effective rate in the intervention group was significantly higher than that in the control group（χ2=19.334，P<0.05）.There was no significant difference in the effective rate of the mild stroke patients between the intervention group and control group（χ2=0.366，P>0.05）,but the effective rate of the moderate and severe stroke patients in the intervention group was significantly higher than that in the control group（χ2=12.752,8.713;P<0.05）.There was no significant difference in the serum ICAM-1 level between the two groups before treatment（Z=-1.213，P>0.05）.The serum ICAM-1 level after treatment was lower than that before treatment in the two groups（Z=-5.238,-7.969;P<0.05）.The serum ICAM-1 level in the intervention group was lower than that in the control group after treatment（Z=-6.644，P<0.05）.During treatment,dizziness and blood pressure drop occurred in 2 patients (2.2%) in the intervention group,and no similar adverse reactions occurred in the control group.No allergic reaction occurred in the two groups.Conclusion　Salvianolic acid can effectively improve the neural function and the ability of daily living in patients with acute LAA stroke.Its mechanism may be through reducing the serum ICAM-1 level and blocking the inflammatory cascade reaction of ischemic brain tissues,so as to play a therapeutic role.

参考文献/References:

［1］　ZHANG J,ZHANG Q,LIU G,et al.Therapeutic potentials and mechanisms of the Chinese traditional medicine Danshensu［J］.Eur J Pharmacol,2019,864:172710.
［2］　QI Y,YU C,TANG L，et al.Patient characteristics associated with treatment response in patients receiving salvianolate injection for stable angina［J］.J Evid Based Med,2018,11(2):83-88.
［3］　JIA D,LI T,CHEN X,et al.Salvianic acid A sodium protects HUVEC cells against tert-butyl hydroperoxide induced oxidative injury via mitochondria-dependent pathway［J］.Chem Biol Interact,2018,279：234-242.
［4］　HU Z,WANG H,FAN G,et al.Danhong injection mobilizes endothelial progenitor cells to repair vascular endothelium injury via upregulating the expression of Akt,eNOS and MMP-9［J］.Phytomedicine,2019,61：152850.
［5］　LYU J,XIE Y M,WANG Z F,et al.Salvianolic acids for injection combined with conventional treatment for patients with acute cerebral infarction:a systematic review and meta-analysis of randomized controlled trials ［J］.Med Sci Monit,2019,25:7914-7927.
［6］　刘媛，彭建伟，孟改，等.丹参多酚酸对急性缺血性脑卒中患者脑灌注影响的临床观察［J］.中华老年心脑血管病杂志，2017，19（7）：739-744.
［7］　于超男，李渊，于风景，等.注射用丹参多酚酸联合肝素治疗进展性脑卒中的临床研究［J］.药物评价研究，2020，43（3）：477-481.
［8］　房阁.注射用丹参多酚酸治疗缺血性脑卒中的临床效果分析［J］.中西医结合心脑血管病杂志，2017,15（6）：725-727.
［9］　中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018［J］.中华神经科杂志，2019，51（9）：666-682.
［10］　ADAMS H P,BENDIXEN B H,KAPPELLE L J,et al.Classification of subtype of acute ischemic stroke：definitions for use in a multicenter clinical trial［J］.Stroke,1993,24(1):35-41.
［11］　全国第四届脑血管学术会议.脑卒中患者临床神经功能缺损程度评分标准：1995［J］.中华神经科杂志，1996，12（9）：381-383.
［12］　GUO C,ZHENG X.Health challenges and opportunities for an aging china［J］.Am J Public Health,2018,108(7):890-892.
［13］　COLLABORATORS G N.Global,regional,and national burden of neurological disorders,1990-2016:a systematic analysis for the Global Burden of Disease Study 2016［J］.Lancet Neurol,2019,18(5):459-480.
［14］　王陇德，刘建民，杨弋，等.《中国脑卒中防治报告2017》 概要［J］.中国脑血管病杂志，2018，11（15）：611-616.
［15］　赵卿，毛芸瑾，沈俭，等.缺血性脑卒中急性期治疗结局影响因素的回顾分析［J］.上海预防医学，2013，25（6）：349-352.
［16］　谭文刚.血管内机械取栓治疗急性脑梗死疗效观察［J］.新乡医学院学报，2019，36（2）：85-88.
［17］　王玉东.静脉溶栓联合动脉取栓治疗急性缺血性脑卒中的疗效及安全性［J］.新乡医学院学报，2019，36（8）：764-767.
［18］　DE LOS ROS LA ROSA F,KHOURY J,KISSELA B M,et al.Eligibility for intravenous recombinant tissue-type plasminogen activator within a population:the effect of the European cooperative acute stroke study (ECASS) III trial［J］.Stroke,2012,43(6):1591-1595.
［19］　PHIPPS M S,CRONIN C A.Management of acute ischemic stroke［J］.BMJ,2020,368：l6983.
［20］　CHAMORRO ,DIRNAGL U,URRA X,et al.Neuroprotection in acute stroke:targeting excitotoxicity,oxidative and nitrosative stress,and inflammation［J］.Lancet Neurol 2016,15(8):869-881.
［21］　刘亚梅，徐 江，李晓芸.养脑通络汤联合氯吡格雷对缺血性脑卒中患者神经功能的影响及机制分析［J］.世界中医药，2019，14（12）：2369-3273.
［22］　王伟伟，张保安，熊小云，等.迷走神经电刺激对缺血性脑卒中大鼠脑损伤及Toll样受体4信号通路的影响［J］.新乡医学院学报，2020，37（3）：225-234.
［23］　武晓磊，冯学功.醒脑平衡针刺法治疗急性缺血性脑卒中患者的临床观察［J］.世界中医药，2019，14（6）：1577-1580.
［24］　徐静瑶，刘小琳，佟玲，等.高效液相色谱法测定注射用丹参多酚酸中6种水溶性成分的含量［J］.中国新药杂志，2015，24（14）：1599-1603.
［25］　贺亚龙，高 焱，郭晓贤.丹参多酚酸治疗急性脑梗死的临床研究［J］.现代药物与临床，2016，31（9）：1354-1359.
［26］　栗延伟，张军艳，兰春伟.丹参多酚酸联合阿加曲班治疗进展性脑梗死疗效观察［J］.新乡医学院学报，2019，36（4）：357-360.
［27］　朱敏，詹增土，王梅平.缺血性中风中医证型分布与血脂、颈动脉超声征象及Hcy的相关性研究［J］.世界中医药，2019，14（4）：1046-1050.
［28］　HERRINGTON W,LACEY B,SHERLIKER P,et al.Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease［J］.Circ Res,2016,118(4):535-546.
［29］　YANG R X,HUANG S Y,YAN F F,et al.Danshensu protects vascular endothelia in a rat model of hyperhomocysteinemia［J］.Acta Pharmacologica Sinica,2010,31(10):1395-1400.
［30］　MULLER W A.How endothelial cells regulate transmigration of leukocytes in the inflammatory response［J］.Am J Pathol,2014,184(4):886-896.
［31］　徐士欣，张军平，李伟，等.丹酚酸B对活化血小板诱导脑微血管内皮细胞炎症应答的影响［J］.中华神经医学杂志，2012，12（10）：1215-1218.
［32］　XU S,ZHONG A,MA H,et al.Neuroprotective effect of salvianolic acid B against cerebral ischemic injury in rats via the CD40/NF-κB pathway associated with suppression of platelets activation and neuroinflammation［J］.Brain Res，2017,1661：37-48.

相似文献/References:

[1]栗延伟,张军艳,兰春伟.丹参多酚酸联合阿加曲班治疗进展性脑梗死疗效观察[J].新乡医学院学报,2019,36(4):357.[doi:10.7683/xxyxyxb.2019.04.014]
　LI Yan-wei,ZHANG Jun-yan,LAN Chun-wei.Clinical efficacy of salvianolate combined with argatroban in the treatment of progressive stroke[J].Journal of Xinxiang Medical University,2019,36(7):357.[doi:10.7683/xxyxyxb.2019.04.014]
[2]李　慧.阿替普酶溶栓后联合丹参多酚酸治疗急性脑梗死的疗效及安全性[J].新乡医学院学报,2019,36(11):1048.[doi:10.7683/xxyxyxb.2019.11.010]
　LI Hui.Efficacy and safety of alteplase combined with danshen polyphenolic acid in treatment of patients with acute cerebral infarction[J].Journal of Xinxiang Medical University,2019,36(7):1048.[doi:10.7683/xxyxyxb.2019.11.010]

更新日期/Last Update: 2020-07-05